Autism and MMR vaccination or thimerosal exposure: An urban legend?

Canadian Journal of Neurological Sciences

Volumn 33, Issue 4, 2006, Pages 339-340

  Shevell, Michael ^a   Fombonne, Eric ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

MEASLES MUMPS RUBELLA VACCINE; PERTUSSIS VACCINE; THIOMERSAL;

AUTISM; DRUG EXPOSURE; EDITORIAL; GEOGRAPHIC DISTRIBUTION; HUMAN; MEASLES; MUMPS; PATHOGENESIS; PERTUSSIS; PREVALENCE; PRIORITY JOURNAL; RUBELLA; SYSTEMATIC REVIEW; VACCINATION;

EID: 33845658139     PISSN: 03171671     EISSN: None     Source Type: Journal    
DOI: 10.1017/S0317167100005278     Document Type: Editorial

References (38)

1. http://en.wikipedia.org\wiki/urban_legend. [Cited 2006 Aug 14].
2. Wakefield AJ, March SH, Anthony A, Linnell J, Casson DM, Malik M, et al. Ileal-lymphoid-nodular hyperplasia, non-specific colitis, and pervasive developmental disorder in children. Lancet. 1998;351:637-41.
3. Murch SH, Anthony A, Casson DH, Malik M, Berelowitz M, Dhillon AP, et al. Retraction of an interpretation. Lancet. 2004;363:750.
4. Halsey N, Hyman S. Conference Writing Panel. Measles, mumps and rubella vaccine and Autism spectrum disorder. Report from the New Challenges in Childhood Immunization Conference convened at Oak Brook, Illinois, June 12-13, 2001. Pediatrics. 2001;107:1-23.
5. Bernard S, Enayati A, Redwood L, Roger H, Binstock T. Autism: a novel form of mercury poisoning. Med Hypotheses. 2001;56:462-71.
6. Doja A, Roberts W. Immunizations & autism: a review of the literature. Can J Neurol Sci. 2006;33:341-346.
7. Madsen KM, Hviid A, Vestergaard M, Schendel D, Wohlfahrt J, Thorsen P, et al. A population-based study of measles, mumps, and rubella vaccination and autism. NEJM. 2002;347:1477-82.
8. Taylor B, Miller E, Farrington CP, Petropoulos MC, Faust-Mayaud I, et al. Autism and measles, mumps, and rubella vaccine: no epidemiological evidence for a causal association. Lancet. 1999;353:2026-9.
9. Chen W, Landau S, Sham P, Fombonne E. No evidence for links between autism, MMR and measles virus. Psychol Med. 2004;34:543-53.
10. Smeeth L, Cook C, Fombonne E, Heavey L, Rodrigues LC, Smith PG, et al. MMR vaccination and pervasive developmental disorders: a case-control study. Lancet. 2004;364:963-9.
11. Makela A, Nuorti JP, Petola H. Neurologic disorders after measles-mumps-rubella vaccination. Pediatrics. 2002;110:957-63.
12. Gillberg C, Heijbel H. MMR and autism. Autism. 1998;2:423-4.
13. Dales L, Hammer SJ, Smith NJ. Time trends in autism and MMR immunization coverage in California. JAMA. 2001;286:1183-5.
14. Honda H, Shimizu Y, Rutter M. No effect of MMR withdrawal on the incidence of autism: a total population study. J Child Psychol Psychiatry. 2005;46:572-9.
15. Fombonne E, Zakarian R, Bennett A, Meng L, McLean-Heywood D. Pervasive developmental disorders in Montreal, Quebec, Canada. Prevalence and links with immunizations. Pediatrics. 2006;118:e139-50.
16. Institute of Medicine. Immunization Safety Review: Vaccines and Autism. Washington, DC: National Academies Press; 2004.
17. Smeeth L, Rodrigues LC, Hall AJ, Fombonne E, Smith PG. Evaluation of adverse effects of vaccines: the case-control approach. Vaccine. 2002;20:2611-7.
18. Fombonne E. Autism & immunization. In: Encyclopedia on early childhood development. Montreal, 2006. p. 1-8.
19. Afzal MA, Ozoemena LC, O'Hare A, Kidger KA, Bentley ML, Minor PD. Absence of detectable measles virus genome sequence in blood of autistic children who have had their MMR vaccination during the routine childhood immunization schedule of UK. J Med Virol. 2006;78:623-30.
20. D'Scouza Y, Ward B, Fombonne E. No evidence of persisting measles virus in peripheral blood mononuclear cells from children with autism spectrum disorder. Pediatrics. (In Press).
21. Andrews N, Miller E, Grant A, Stowe J, Osborne V, Taylor B. Thimerosal exposure in infants and developmental disorders: a retrospective cohort study in the United Kingdom does not support a causal association. Pediatrics. 2004;114:584-91.
22. Heron J, Golding J. Thimerosal exposure in infants and developmental disorders: a prospective cohort study in the United Kingdom does not support a causal association. Pediatrics. 2004;577-83.
23. Hviid A, Stellfeld M, Wohlfahrt J, Melbye M. Association between thimerosal-containing vaccine and autism. JAMA. 2003;290: 1763-6.
24. Verstraeten T, Davis RL, DeStefano F, Lieu TA, Rhodes PH, Black SB, et al. Safety of thimerosal-containing vaccines: a two-phased study of computerized health maintenance organization databases. Pediatrics. 2003;112:1039-48.
25. Madsen KM, Lauritsen MB, Pedersen CB, Thorsen PB, Plesner AM, Andersen PH, et al. Thimerosal and the occurrence of autism: negative ecological evidence from Danish population-based data. Pediatrics. 2003;112:604-6.
26. Stehr-Green P, Tull P, Stellfeld M, Mortenson PB, Simpson D. Autism and thimerosal-containing vaccines: lack of consistent evidence for an association. AM J Prev Med. 2003;25:101-6.
27. Parker SK, Schwartz B, Todd J, Pickering LK. Thimerosal-containing vaccines and autistic spectrum disorder: a critical review of published original data. Pediatrics. 2004;114:793-804.
28. Ip P, Wong V, Ho M, Lee J, Wong W. Mercury exposure in children with autistic spectrum disorder: case-control study. J Child Neurol. 2004;19:431-4.
29. American Psychiatric Association. Diagnostic and statistical manual of mental disorders, 4th ed. Washington D.C.: American Psychiatric Association; 1994.
30. Filipek PA, Accardo PA, Baranek GT, Cook EH Jr, Dawson G, Gordon B, et al. The screening and diagnosis of autistic spectrum disorders. J Aut Dev Dis. 1999;29:439-84.
31. Shevell MI, Majnemer A, Rosenbaum P, Abrahamowicz M. Etiologic yield of autistic spectrum disorders: a prospective study. J Child Neurol. 2001;16:509-12.
32. Hiotz DG, Wojnr A, Filipek PA. Autistic spectrum disorders. In: Swaiman K, Ashwal S, Ferreir M, editors. Pediatric Neurology: Principle and Practice (4th Ed). Philadelphia: Mosby Elsevier; 2006. p. 905-936.
33. Salmon DA, Haber M, Gangarosa EJ, Phillips L, Smith NJ, Chen RT. Health consequences of religious and philosophical exemptions from immunization laws: individual and societal risk of measles. JAMA. 1999;282:47-53.
34. Griffin MR, Ray WA, Mortimer EA, Fenichel GM, Schaffer W. Risk of seizures and encephalopathy after immunizations with the diphtheria-tetanus- pertussis vaccine. JAMA. 1990;263:1640-45.
35. Jansen VA, Stollenwerk N, Jensen HJ, Ramsay ME, Edmunds WJ, Rhodes CJ. Measles outbreaks in a population with declining vaccine uptake. Science. 2003;301:804.
36. Shannon M, Levy S, Sandler A. Chelation therapy neither safe nor effective as autism treatment. AAP news 2001:63.
37. Muhle R, Trentacose SV, Rapin I. The genetics of autism. Pediatrics 2004;113. Available from: www.pediatrics.org/cgi/content/full/113/5/e472.
38. Helsat MR, Caviness Jr VS. Neuroanatomy and imaging studies. In: Autism: a neurological disorder of early brain development. London: Mckneill Press; 2006. p. 115-40.